Cargando…
A Systematic Review of Immune Checkpoint Inhibitors in Non-Clear-Cell Renal Cancer
BACKGROUND: Immune checkpoint inhibitors (ICI) have emerged as active therapies in the management of advanced RCC. While multiple studies have shown clinical activity of ICIs in clear cell histologies, the evidence to support their use in non-clear cell (ncc) subtypes is based on smaller prospective...
Autores principales: | Palma dos Reis, Ana Filipa, Simão, Diana, Odeny, Thomas, Rodrigues, Chiara, Fontes-Sousa, Mário, da Luz, Ricardo, Chowdry, Rajasree Pia, Welsh, Sarah J., Paller, Channing, Barata, Pedro C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490428/ https://www.ncbi.nlm.nih.gov/pubmed/36212797 http://dx.doi.org/10.3233/KCA-210012 |
Ejemplares similares
-
Antibody-Drug Conjugates in Prostate Cancer: A Systematic Review
por: Sardinha, Mariana, et al.
Publicado: (2023) -
Hemophagocytic Lymphohistiocytosis as the Initial Presentation of
Subcutaneous Panniculitis-Like T-Cell Lymphoma: A Rare Case Responding to
Cyclosporine A and Steroids
por: Sullivan, Caitlin, et al.
Publicado: (2020) -
(177)Lu-PSMA Radioligand Therapy Is Favorable as Third-Line Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
por: von Eyben, Finn E., et al.
Publicado: (2021) -
PSMA Theranostics: Review of the Current Status of PSMA-Targeted Imaging and Radioligand Therapy
por: Jones, Wallace, et al.
Publicado: (2020) -
Therapeutic Potential of PARP Inhibitors in the Treatment of Metastatic Castration-Resistant Prostate Cancer
por: Jang, Albert, et al.
Publicado: (2020)